Posttransplant Lymphoproliferative Disorder Following Kidney Transplantation: A Review
Authors:
- 1 August 2021
- journal article
- review article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 78 (2) , 272-281
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- Post-Transplantation Lymphoproliferative Disorder After Kidney Transplantation: Report of a Nationwide French Registry and the Development of a New Prognostic ScoreJournal of Clinical Oncology, 2013
- The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applicationsBlood, 2011
- Risk factors for early‐onset and late‐onset post‐transplant lymphoproliferative disorder in kidney recipients in the United StatesAmerican Journal of Hematology, 2010
- The Epstein-Barr Virus (EBV)-Encoded Protein Kinase, EBV-PK, but Not the Thymidine Kinase (EBV-TK), Is Required for Ganciclovir and Acyclovir Inhibition of Lytic Viral ProductionJournal of Virology, 2010
- The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disordersHaematologica, 2010
- Multicenter Analysis of 80 Solid Organ Transplantation Recipients With Post-Transplantation Lymphoproliferative Disease: Outcomes and Prognostic Factors in the Modern EraJournal of Clinical Oncology, 2010
- Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantationBlood, 2009
- Epstein–Barr virus, rapamycin, and host immune responsesCurrent Opinion in Organ Transplantation, 2008
- Dissociation of Depletional Induction and Posttransplant Lymphoproliferative Disease in Kidney Recipients Treated With AlemtuzumabAmerican Journal of Transplantation, 2007
- A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus–associated lymphoid malignanciesBlood, 2006